News from genvec, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-SMALL:GNVC)

Jan 20, 2016, 07:00 ET

GenVec Provides Investor Update

 GenVec, Inc. (NASDAQ: GNVC), a clinical-stage gene delivery company, provided an update to investors on recent developments and the company's...

Dec 02, 2015, 08:00 ET

GenVec Receives Notice of Allowance for Patent Application Providing Broad Protection of Its Gorilla Adenovectors

 GenVec, Inc. (NASDAQ: GNVC), a clinical-stage gene delivery company, announced today that it received a notice of allowance for its patent...

Nov 09, 2015, 08:00 ET

GenVec Reports Third Quarter 2015 Financial Results

GenVec, Inc. (NASDAQ: GNVC), a clinical-stage gene delivery company, reported financial results for the third quarter ended September 30, 2015. For...

Nov 04, 2015, 08:00 ET

GenVec Highlights Gorilla Adenovectors At Vaccines R&D-2015 Conference

 GenVec, Inc. (NASDAQ: GNVC), a clinical-stage gene delivery company, announced that Douglas E. Brough, Ph.D., the company's chief scientific...

Sep 30, 2015, 08:00 ET

GenVec To Present At 2015 Stem Cell Meeting On The Mesa

 GenVec, Inc. (NASDAQ: GNVC) announced that Douglas E. Brough, Ph.D., the company's chief scientific officer, will provide a brief review of...

Sep 28, 2015, 08:00 ET

GenVec Expands I.P. Portfolio With Issuance Of U.S. And European Patents For Monkey Adenoviral Vectors

 GenVec, Inc. (NASDAQ: GNVC) today announced that on September 15, 2015, the U.S. Patent and Trademark Office issued patent 9133248, covering...

Aug 07, 2015, 08:00 ET

GenVec Reports Second Quarter 2015 Financial Results

 GenVec, Inc. (NASDAQ: GNVC) today reported financial results for the second quarter ended June 30, 2015. For the three months ended June 30,...

Jun 03, 2015, 08:00 ET

GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines

 GenVec, Inc. (NASDAQ: GNVC) today announced a multi-faceted collaboration with Dr. David T. Curiel and his team from the School of Medicine at...

May 28, 2015, 08:00 ET

GenVec To Present At The Jefferies Healthcare Conference

 GenVec, Inc. (Nasdaq: GNVC) today announced that its president and CEO, Douglas J. Swirsky, will present a company overview at the Jefferies...

May 14, 2015, 08:00 ET

GenVec Highlights Proprietary Gorilla Vectors At ASGCT Presentation

GenVec, Inc. (NASDAQ: GNVC) announced today that Douglas E. Brough, the company's chief scientific officer, gave a presentation entitled "Gorilla...

May 08, 2015, 07:30 ET

GenVec Reports First Quarter 2015 Financial Results

 GenVec, Inc. (NASDAQ: GNVC) today reported financial results for the first quarter ended March 31, 2015. For the three months ended March 31,...

Apr 22, 2015, 08:00 ET

Michael Richman Appointed To GenVec Board Of Directors

GenVec, Inc. (NASDAQ: GNVC) today announced that the Board of Directors of GenVec, Inc. appointed Michael Richman as a director of the...

Apr 21, 2015, 08:01 ET

GenVec Announces Collaboration with the Laboratory of Malaria Immunology & Vaccinology

 GenVec, Inc. (NASDAQ: GNVC) today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology...

Mar 24, 2015, 07:00 ET

GenVec Reports Fourth Quarter And 2014 Year-End Financial Results

 GenVec, Inc. (NASDAQ: GNVC) today reported financial results for the fourth quarter and year ended December 31, 2014. For the year ended...

Mar 23, 2015, 07:00 ET

GenVec and TheraBiologics form Collaboration to Develop Neural Stem Cell Mediated Cancer Therapies

GenVec, Inc. (NASDAQ: GNVC) today announced that it has formed a collaboration with TheraBiologics to develop cancer therapeutics leveraging both...

Mar 17, 2015, 08:00 ET

GenVec to Release Fourth Quarter and Year-End 2014 Financial Results and Conduct a Conference Call on March 24, 2015

 GenVec, Inc. (NASDAQ: GNVC) will report financial results for the fourth quarter and year ended December 31, 2014 on Tuesday, March 24, 2015,...

Mar 02, 2015, 08:00 ET

GenVec To Present At The 27th Annual ROTH Conference

 GenVec, Inc. (Nasdaq: GNVC) today announced that its President and CEO, Douglas J. Swirsky, will present a corporate overview at the 27th...

Feb 02, 2015, 08:00 ET

GenVec To Present At The 17th Annual BIO CEO & Investor Conference

GenVec, Inc. (Nasdaq: GNVC) today announced that its President and CEO, Douglas J. Swirsky, will present a corporate overview at the 17th Annual...

Nov 12, 2014, 07:55 ET

GenVec Reports Third Quarter 2014 Financial Results

 GenVec, Inc. (NASDAQ: GNVC) today reported financial results for the three-month and nine-month periods ended September 30, 2014. For the...

Nov 11, 2014, 07:30 ET

Preclinical Data For GenVec's RSV Vaccine Candidate Presented At The 9th RSV Symposium

 GenVec, Inc. (NASDAQ: GNVC) today announced that data exploring the immune responses generated by its vaccine candidate, GV2311, were...